Medical cannabis offers relief for head and neck cancer patients

Head and neck cancers present a complex array of debilitating symptoms that extend far beyond the tumors themselves. Patients struggle with severe pain, nausea, difficulty swallowing, and dry mouth, often worsened by aggressive treatments like surgery, radiation, and chemotherapy. These side effects can dramatically reduce quality of life and complicate recovery. Medical cannabis has emerged as a promising supportive therapy for this population, with research showing effectiveness in managing chronic pain, nausea, and anxiety through interactions with the endocannabinoid system.

The endocannabinoid system plays a crucial role in regulating pain perception (nociception) and inflammatory responses throughout the body, making cannabis a particularly suitable option for the symptom burden faced by head and neck cancer patients. Beyond pain relief, medical cannabis may help address cachexia (severe weight loss) and appetite suppression, allowing patients to maintain nutrition during treatment. The cannabinoids in cannabis work by reducing inflammation and modulating pain signals, addressing multiple symptoms simultaneously rather than requiring separate medications for each complaint.

This review highlights medical cannabis as a valuable component of comprehensive supportive care for head and neck cancer patients, complementing conventional treatments without replacing them. As standard cancer therapies become increasingly effective but more taxing on patients, integrating medical cannabis into symptom management protocols could significantly improve quality of life and treatment tolerance. The approach emphasizes cannabis not as a cure, but as an essential tool for helping patients maintain dignity, nutrition, and psychological well-being during their cancer journey.